/Companies

Apriori Bio

22 employees on LinkedIn · 3 known investors

Find your way into Apriori Bio

Sign up to see every warm intro you have to Apriori Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Apriori Bio team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Apriori Bio applies AI/ML combined with biological insights to predict how viruses evolve and to design vaccines, assessing their expected performance before clinical trials. The company operates in the vaccinology and biotech space.

Investors · 3

Also in the syndicate · 1

CEPI

Funding

SEC filings, press & company announcements

$1.1M disclosed across 1 round · 2024

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Apriori Bio went on to found or lead other companies.

In the news

Frequently asked questions

What does Apriori Bio do?
Apriori Bio applies AI/ML combined with biological insights to predict how viruses evolve and to design vaccines, assessing their expected performance before clinical trials. The company operates in the vaccinology and biotech space.
Who are Apriori Bio's investors?
Apriori Bio's investors include Flagship Pioneering, Global Health Investment Corporation.
How much funding has Apriori Bio raised?
Apriori Bio has disclosed $1.1M raised across 1 round.